Fresh analysis indicates that patients who stop using new weight-loss injections like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who stop traditional lifestyle regimens.
Published data in a leading medical journal demonstrates that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing these medications should be informed of the danger of rapid rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.
Such speed of regain suggests a reversion to pre-treatment mass in about a year and a half.
Analyzing Therapies
The research, which reviewed dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.
Researchers emphasize that people who lose weight through dieting usually experience a less rapid weight regain—around 100 grams monthly—once they finish.
Explaining the Quick Regain
Doctors suggest the way of the injections is key to understanding the accelerated rebound.
The injections copy a body's own chemical called GLP-1, which controls appetite.
"Long-term administration of the hormone levels far above than normal could lead to the system to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means hunger is no longer kept in check, making binge eating much more probable."
A Chronic Disease?
The NHS advise the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the significant potential of relapse, the treatment should be considered ongoing.
This perspective is supported by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," similar to managing conditions like hypertension.
User Testimonies
People who have come off the medication explain a intense resurgence of cravings.
"It felt as if something activating and I was suddenly starving," described one woman.
This difficulty is compounded if individuals have not developed lasting lifestyle or habit changes during therapy.
Significant Adoption
Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.
- Adoption is more common among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than the NHS.
Finally, experts emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a permanent cure and maintained weight loss hinges on integrated lifestyle changes.
